Yehong Zhuo Selected Research

growth differentiation factor 7

1/2021

TET-dependent GDF7 hypomethylation impairs aqueous humor outflow and serves as a potential therapeutic target in glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yehong Zhuo Research Topics

Disease

24	Glaucoma 08/2022 - 01/2008
6	Ganglion Cysts (Ganglion) 08/2022 - 11/2010
6	Inflammation (Inflammations) 01/2022 - 01/2014
5	Reperfusion Injury 07/2022 - 01/2020
4	Blister (Bulla) 03/2022 - 11/2010
3	Ocular Hypertension (Glaucoma, Suspect) 08/2022 - 09/2010
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 03/2022 - 06/2010
3	Alzheimer Disease (Alzheimer's Disease) 10/2017 - 06/2011
3	Cicatrix (Scar) 05/2017 - 01/2008
2	Neuroinflammatory Diseases 01/2022 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 11/2020
2	Infections 01/2021 - 01/2012
2	Dry Eye Syndromes (Dry Eye Syndrome) 05/2017 - 01/2016
2	Corneal Edema 02/2015 - 12/2013
2	Pain (Aches) 07/2014 - 12/2013
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2022
1	Blindness (Hysterical Blindness) 01/2022
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2022
1	Eye Diseases (Eye Disease) 01/2022
1	Fibrosis (Cirrhosis) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Necrosis 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2020
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 11/2020
1	Hypertensive Retinopathy 11/2020
1	Ischemia 11/2020
1	Corneal Neovascularization 01/2020
1	Corneal Injuries 01/2020
1	Retinal Neovascularization 01/2019
1	Cataract (Cataracts) 01/2019
1	Optic Nerve Injuries 10/2017
1	Tauopathies 10/2017
1	Amyloid Plaque 10/2017
1	Pathologic Processes 01/2017
1	Retinal Diseases 01/2017

Drug/Important Bio-Agent (IBA)

16	Retinaldehyde (Retinal)IBA 07/2022 - 09/2010
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2010
4	CytokinesIBA 01/2022 - 09/2017
4	Caspase 8 (Caspase-8)IBA 11/2020 - 07/2014
3	laquinimodIBA 07/2022 - 01/2020
3	Neuroprotective AgentsIBA 01/2022 - 01/2017
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2010
3	Amyloid (Amyloid Fibrils)IBA 10/2017 - 06/2011
2	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2022
2	Beclin-1IBA 01/2022 - 01/2013
2	Long Noncoding RNAIBA 01/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
2	Caspase 3 (Caspase-3)IBA 01/2022 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 12/2010
2	ZincIBA 01/2021 - 10/2017
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2017 - 01/2017
2	InflammasomesIBA 07/2015 - 07/2014
2	Biological ProductsIBA 12/2010 - 08/2010
2	Small Interfering RNA (siRNA)IBA 11/2010 - 01/2008
1	HydrogelsIBA 08/2022
1	Competitive Endogenous RNAIBA 06/2022
1	Circular RNAIBA 06/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2022
1	8-hydroxyguanosineIBA 01/2022
1	DNA Ligase ATPIBA 01/2022
1	AntibodiesIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	InterleukinsIBA 01/2022
1	SteroidsIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021
1	IronIBA 01/2021
1	growth differentiation factor 7IBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2020
1	AlkaliesIBA 01/2020
1	ChemokinesIBA 01/2020
1	ArtesunateIBA 01/2019
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2019
1	tau Proteins (tau Protein)IBA 10/2017
1	SilverIBA 10/2017
1	Trimetazidine (Vastarel)IBA 09/2017
1	Biocompatible Materials (Biomaterials)IBA 01/2017
1	HMGB1 Protein (HMG1)IBA 07/2015
1	SolutionsIBA 07/2015
1	SaltsIBA 07/2015
1	4-O-carboxymethylascochlorinIBA 07/2015

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2017
3	Filtering Surgery 05/2017 - 01/2008
2	Trabeculectomy (Trabeculoplasty) 03/2022 - 01/2016
2	Lasers (Laser) 01/2022 - 02/2015
1	Intracameral Injection 08/2022
1	Intraocular Injections 01/2022
1	Transjugular Intrahepatic Portasystemic Shunt 01/2020
1	Topical Administration 01/2020
1	Intravitreal Injections 01/2019
1	Injections 01/2019